Depatuxizumab mafodotin Antibody
Depatuxizumab mafodotin is an EGFR-targeting antibody-drug conjugate (ADC) used in oncology research. It is employed in both in vitro and in vivo studies to investigate its mechanisms and therapeutic potential against EGFR-expressing cancers, such as glioblastoma.
Product Specifications
Target
Antibody-Drug Conjugates (ADCs), EGFR
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog